1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Neidigh, J.W. Fesinmeyer, R.M. Prickett, K.S. Andersen, N.H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 40 13188 13200 10.1021/bi010902s 11683627 Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states. 2001 10.2210/pdb1jrj/pdb pdb_00001jrj 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 4191.588 Exendin-4 1 syn polymer no no HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2001-11-21 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name RCSB Y RCSB 2001-08-13 REL REL The protein was produced using FMOC synthesis. The sequence occurs naturally in the salivary secretion of Heloderma suspectum (Gila monster). sample 2D NOESYs performed with mixing times of 60, 150 (deuterated medium), 160ms. structures with acceptable covalent geometry, structures with favorable non-bond energy, structures with the least restraint violations 50 36 2D NOESY 2D TOCSY 15mM potassium phosphate 5.9 ambient 280 K The structures were calculated using CNS 0.9 with 294 NOE distance constraints, 20 distance constraints from defined torsion angles, and 116 anti-distance constraints. No hydrogen bond constraints were employed. simulated annealing Natural abundance 2mg/ml in pH 5.9 15mM phosphate buffer with 30 vol-% trifluoroethanol added Bruker collection XwinNMR MSI processing Felix 95 Brunger structure solution CNS 0.9 Brunger refinement CNS 0.9 750 Bruker DMX HIS 1 n 1 HIS 1 A GLY 2 n 2 GLY 2 A GLU 3 n 3 GLU 3 A GLY 4 n 4 GLY 4 A THR 5 n 5 THR 5 A PHE 6 n 6 PHE 6 A THR 7 n 7 THR 7 A SER 8 n 8 SER 8 A ASP 9 n 9 ASP 9 A LEU 10 n 10 LEU 10 A SER 11 n 11 SER 11 A LYS 12 n 12 LYS 12 A GLN 13 n 13 GLN 13 A MET 14 n 14 MET 14 A GLU 15 n 15 GLU 15 A GLU 16 n 16 GLU 16 A GLU 17 n 17 GLU 17 A ALA 18 n 18 ALA 18 A VAL 19 n 19 VAL 19 A ARG 20 n 20 ARG 20 A LEU 21 n 21 LEU 21 A PHE 22 n 22 PHE 22 A ILE 23 n 23 ILE 23 A GLU 24 n 24 GLU 24 A TRP 25 n 25 TRP 25 A LEU 26 n 26 LEU 26 A LYS 27 n 27 LYS 27 A ASN 28 n 28 ASN 28 A GLY 29 n 29 GLY 29 A GLY 30 n 30 GLY 30 A PRO 31 n 31 PRO 31 A SER 32 n 32 SER 32 A SER 33 n 33 SER 33 A GLY 34 n 34 GLY 34 A ALA 35 n 35 ALA 35 A PRO 36 n 36 PRO 36 A PRO 37 n 37 PRO 37 A PRO 38 n 38 PRO 38 A SER 39 n 39 SER 39 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A SER 32 -95.24 44.50 2 A SER 32 -90.75 46.30 3 A THR 5 -115.56 67.70 3 A SER 32 -99.26 41.39 3 A PRO 38 -89.14 43.68 4 A GLU 3 70.20 156.21 4 A THR 5 -94.93 39.63 5 A GLU 3 63.78 87.49 6 A PHE 6 -106.14 -62.99 6 A THR 7 73.53 -57.94 6 A SER 32 -98.49 34.51 7 A GLU 3 63.04 95.52 7 A THR 5 -141.64 49.02 7 A SER 32 -95.00 33.22 8 A SER 32 -99.50 39.51 9 A THR 5 63.62 78.57 10 A SER 32 -95.88 30.94 11 A THR 5 -151.58 89.73 11 A SER 32 -96.21 33.71 12 A THR 5 70.87 104.12 12 A SER 32 -92.50 33.93 13 A THR 5 -113.93 51.44 13 A PHE 6 -120.84 -60.97 13 A THR 7 74.19 -55.82 13 A SER 32 -96.39 40.94 15 A GLU 3 64.19 103.23 15 A SER 32 -94.99 42.46 16 A GLU 3 62.57 89.25 16 A THR 5 -116.46 50.97 16 A PHE 6 -162.00 79.28 16 A SER 32 -97.13 40.82 17 A SER 32 -96.29 40.95 18 A THR 5 59.34 86.74 18 A SER 32 -95.36 50.76 19 A SER 32 -100.84 41.25 20 A THR 5 -119.35 73.23 20 A THR 7 74.01 -55.50 21 A THR 5 61.44 71.72 21 A SER 32 -95.84 38.72 22 A SER 32 -94.92 42.65 23 A SER 32 -97.22 32.10 24 A PHE 6 -141.79 -62.07 24 A THR 7 74.63 -56.99 24 A SER 32 -88.53 48.68 25 A THR 5 69.90 103.02 25 A PHE 6 -102.19 -70.29 25 A THR 7 71.28 -56.82 25 A SER 32 -96.84 37.74 26 A SER 32 -91.00 53.32 27 A SER 32 -98.34 30.75 28 A THR 5 67.66 99.89 29 A THR 5 62.80 79.93 30 A THR 5 -156.79 38.55 31 A SER 32 -93.33 41.49 32 A GLU 3 65.15 79.54 32 A THR 5 -107.47 49.18 32 A SER 32 -98.92 38.49 33 A SER 32 -93.85 34.97 34 A GLU 3 68.56 155.96 34 A THR 5 -123.97 -120.53 35 A THR 5 38.73 66.56 36 A THR 7 75.96 -55.88 Solution structure of exendin-4 in 30-vol% trifluoroethanol 1 N N A PHE 6 A PHE 6 HELX_P A ASN 28 A ASN 28 1 1 23 A GLY 29 A GLY 29 HELX_P A SER 33 A SER 33 5 2 5 HORMONE/GROWTH FACTOR Trp-cage, GLP-1, poly-proII, hydrophobic cluster, HORMONE-GROWTH FACTOR COMPLEX EXE4_HELSU UNP 1 1 P26349 HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS 1 39 1JRJ 1 39 P26349 A 1 1 39